Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Permanent hair loss from chemotherapy significantly impacts patients' mental health and social life, highlighting the need for better patient education and support.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

PLGA nanospheres in cosmetics improve skin and hair treatment effectiveness.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Oral cyclosporine combined with Pantogar® effectively treats twenty-nail dystrophy.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Chemotherapy causes hair loss, nausea, fatigue, and blood issues, but counseling can help manage these effects.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Birds can lose neck feathers due to a genetic change that increases a gene's activity, helping them adapt to heat.

IGF-1 may affect hair growth and loss, but more research is needed to confirm effective and safe treatments.

Neurotrophin-4 increases calcium current in specific mouse neurons through the PI3K pathway.

Dynamic, light touch is sensed through a common mechanism involving Piezo2 channels in sensory axons.

Kir6.1 mutations in Cantú syndrome increase channel sensitivity and hyperpolarization, while SUR2B mutations do not.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

The microneedle system shows promise for non-invasive brain drug delivery.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

Some drugs for inflammation may cause psoriasis-like hair loss.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Paxillin may help manage androgen-related disorders like PCOS by stabilizing androgen receptor proteins.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

A woman kept her eyelashes during chemotherapy possibly because of her glaucoma eye drops.

Chemotherapy causes permanent hair follicle damage by triggering stem cell loss.